daunorubicin has been researched along with camptothecin in 37 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (16.22) | 18.7374 |
| 1990's | 8 (21.62) | 18.2507 |
| 2000's | 14 (37.84) | 29.6817 |
| 2010's | 8 (21.62) | 24.3611 |
| 2020's | 1 (2.70) | 2.80 |
| Authors | Studies |
|---|---|
| Baguley, BC; Deady, LW; Denny, WA; Rodemann, T; Zhuang, L | 1 |
| Cho, WJ; Kim, TS; Le, TN; Min, SY | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, YL; Cheng, CM; Han, CH; Lin, SR; Peng, SI; Tseng, CH; Tzeng, CC; Yang, SH | 1 |
| Lowary, TL; Marcus, SL; Shi, W | 1 |
| Chen, YL; Chen, YW; Liang, CC; Lu, PJ; Tseng, CH; Tzeng, CC; Yang, CN; Yao, YC | 1 |
| Anikina, LV; Gazieva, GA; Karpova, TB; Kolotyrkina, NG; Kravchenko, AN; Nechaeva, TV; Nelyubina, YV; Popkov, SV; Pukhov, SA | 1 |
| Anikina, LV; Babkov, DA; Bezsonova, EN; Borisov, AV; Efremov, AM; Lozinskaya, NA; Perfilova, VN; Proskurnina, MV; Spasov, AA; Tsymlyakov, MD; Tyurenkov, IN; Zakharyascheva, OY; Zaryanova, EV | 1 |
| Chatterjee, DR; Contractor, D; Jain, A; Kumar, D; Nagpure, M; Rana, P; Satpute, DP; Vaidya, GN; Venkatesh, A | 1 |
| Coetzee, ML; Klein, K; Ove, P; Sartiano, GP | 1 |
| Dimmock, NJ; Minor, PD | 1 |
| Moore, HW | 1 |
| Sumner, AT | 1 |
| Beck, WT; Danks, MK | 1 |
| Kaufmann, SH | 1 |
| Kann, HE; Kohn, KW | 1 |
| Bergevin, PR; Blom, J; Tormey, DC | 1 |
| Tobey, RA | 1 |
| Adjei, A; Burke, PJ; Cheng, YC; Donehower, RC; Gore, SD; Grochow, LB; Jones, RJ; Kaufmann, SH; Rowinsky, EK | 1 |
| Piette, J; Piret, B | 1 |
| Allouche, M; Dubrez, L; Eymin, B; Solary, E | 1 |
| Falaschi, A; Ochem, A; Phan, TN; Tuteja, N; Tuteja, R | 1 |
| Phan, TN; Tuteja, N | 1 |
| Bonnefoy-Berard, N; Ferraro, C; Prigent, AF; Quemeneur, L; Revillard, JP; Taverne, C | 1 |
| Choi, CH; Chung, MH; Jeong, JH; Kim, HS; Kim, MS; Kweon, OS; Lee, TB; Lim, DY; Min, YD; Rha, HS; You, HJ | 1 |
| Bascans, E; Belaud-Rotureau, MA; Belloc, F; Braz-Pereira, E; Durrieu, F; Lacombe, F; Lavignolle, V | 1 |
| Burke, T; Zoorob, G | 1 |
| Davey, M; Davey, R; Locke, V | 1 |
| Baptiste, N; Chen, X; Friedlander, P; Prives, C | 1 |
| Chauvier, D; Manfait, M; Morjani, H | 1 |
| Chauvier, D; Kegelaer, G; Manfait, M; Morjani, H | 1 |
| Ishikawa, T; Kamachi, T; Nakagawa, H; Okura, I; Saito, H; Tamura, A; Watanabe, M | 1 |
| Bally, MB; Harasym, NL; Harasym, TO; Janoff, AS; Johnstone, SA; Mayer, LD; Ramsay, EC; Shew, CR; Tardi, PG | 1 |
| Barge, RM; de Vries, JF; Falkenburg, JH; Heemskerk, MH; Jedema, I; Nijmeijer, BA; van Dreunen, L; Wammes, LJ; Willemze, R | 1 |
| Bleibel, WK; Cook, E; Eileen Dolan, M; Hennessy, K; Innocenti, F; Liu, W; Mirkov, S; Nagasubramanian, R; Ramírez, J; Ratain, MJ; Rosner, GL; Shukla, SJ | 1 |
| Pham, XH; Tran, NQ; Tuteja, N; Tuteja, R | 1 |
| Carie, A; Semple, JE; Sill, KN; Sullivan, B | 1 |
3 review(s) available for daunorubicin and camptothecin
| Article | Year |
|---|---|
Paradigm shift of "classical" HDAC inhibitors to "hybrid" HDAC inhibitors in therapeutic interventions.
Topics: Animals; Cardiovascular Diseases; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Humans; Molecular Targeted Therapy; Neoplasms; Nervous System Diseases | 2021 |
Mechanisms of resistance to drugs that inhibit DNA topoisomerases.
Topics: Amsacrine; Animals; Antineoplastic Agents; Camptothecin; Cricetinae; Daunorubicin; DNA Replication; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Etoposide; Humans; Mice; Teniposide; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1991 |
Guide to the use of cancer chemotherapeutic agents.
Topics: Alkylating Agents; Allopurinol; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Asparaginase; Azaserine; Azauridine; Bleomycin; Camptothecin; Carmustine; Cell Division; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Doxorubicin; Fluorouracil; Humans; Kinetics; Neoplasms; Nitrogen Mustard Compounds; Procarbazine; Triazines; Vincristine | 1972 |
1 trial(s) available for daunorubicin and camptothecin
| Article | Year |
|---|---|
Phase I and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory acute leukemia.
Topics: Acute Disease; Adult; Aged; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blotting, Western; Camptothecin; Daunorubicin; Drug Administration Schedule; Drug Resistance, Multiple; Female; Follow-Up Studies; Humans; Immunohistochemistry; Leukemia; Male; Middle Aged; Mouth Mucosa; Quinidine; Remission Induction; Stomatitis; Topoisomerase I Inhibitors; Topotecan; Tumor Cells, Cultured; Tumor Stem Cell Assay | 1994 |
33 other study(ies) available for daunorubicin and camptothecin
| Article | Year |
|---|---|
Synthesis and cytotoxic activity of carboxamide derivatives of benzo[b][1,6]naphthyridines.
Topics: Animals; Antineoplastic Agents; Cell Division; Drug Screening Assays, Antitumor; Humans; Mice; Naphthyridines; Neoplasm Transplantation; Neoplasms, Experimental; Structure-Activity Relationship; Transplantation, Heterologous; Tumor Cells, Cultured | 2003 |
Synthesis of new 3-arylisoquinolinamines: effect on topoisomerase I inhibition and cytotoxicity.
Topics: Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Cell Survival; DNA Topoisomerases, Type I; Enzyme Inhibitors; Female; Humans; Indicators and Reagents; Isoquinolines; Models, Molecular; Molecular Conformation; Molecular Structure; Protein Conformation; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2003 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis and antiproliferative evaluation of certain iminonaphtho[2,3-b]furan derivatives.
Topics: Antineoplastic Agents; Benzofurans; Cell Cycle; Cell Line; Cell Line, Tumor; Cell Proliferation; DNA Fragmentation; Drug Screening Assays, Antitumor; Fibroblasts; Humans; Imines; Neoplasms | 2010 |
Cytotoxicity and topoisomerase I/II inhibition of glycosylated 2-phenyl-indoles, 2-phenyl-benzo[b]thiophenes and 2-phenyl-benzo[b]furans.
Topics: Benzofurans; Cell Line, Tumor; Drug Screening Assays, Antitumor; Glycosylation; Humans; Indoles; Inhibitory Concentration 50; Thiophenes; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2011 |
Discovery of 4-anilinofuro[2,3-b]quinoline derivatives as selective and orally active compounds against non-small-cell lung cancers.
Topics: Administration, Oral; Aniline Compounds; Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Lung Neoplasms; Mice; Mice, Nude; Mitosis; Models, Molecular; Neoplasm Transplantation; Oximes; Quinolines; Solubility; Stereoisomerism; Structure-Activity Relationship; Tissue Distribution; Topoisomerase Inhibitors; Transplantation, Heterologous | 2011 |
Synthesis and biological evaluation of new substituted thioglycolurils, their analogues and derivatives.
Topics: Antifungal Agents; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fungi; Humans; Imidazolidines; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2017 |
Synthesis and biological evaluation of 3-substituted 2-oxindole derivatives as new glycogen synthase kinase 3β inhibitors.
Topics: A549 Cells; Animals; Binding Sites; Catalytic Domain; Cell Survival; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Glycogen Synthase Kinase 3 beta; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Oxindoles; Protein Kinase Inhibitors; Rats; Structure-Activity Relationship | 2019 |
The effect of several antitumor agents on 3H-TTP incorporation in host liver and hepatoma nuclei.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Camptothecin; Carcinoma, Hepatocellular; Cell Nucleus; Daunorubicin; DNA; DNA, Neoplasm; DNA, Single-Stranded; Doxorubicin; In Vitro Techniques; Liver; Liver Neoplasms; Male; Mitomycins; Neoplasms, Experimental; Plicamycin; Rats; Thymidine | 1977 |
Selective inhibition of influenza virus protein synthesis by inhibitors of DNA function.
Topics: 4-Nitroquinoline-1-oxide; Camptothecin; Cell Line; Dactinomycin; Daunorubicin; Echinomycin; Ethidium; Hemagglutinins, Viral; Influenza A virus; Neuraminidase; Newcastle disease virus; Nogalamycin; Plicamycin; Proflavine; Viral Proteins; Virus Replication | 1977 |
Bioactivation as a model for drug design bioreductive alkylation.
Topics: Alkenes; Alkylating Agents; Amines; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Biotransformation; Camptothecin; Daunorubicin; Doxorubicin; Lactams; Lactones; Mitomycins; Models, Chemical; Quinones; Structure-Activity Relationship | 1977 |
Inhibitors of topoisomerases do not block the passage of human lymphocyte chromosomes through mitosis.
Topics: Amsacrine; Camptothecin; Chromosome Aberrations; Chromosomes, Human; Daunorubicin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Ellipticines; Ethidium; Etoposide; Humans; In Vitro Techniques; Lymphocytes; Mitosis; Mitoxantrone; Nalidixic Acid; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1992 |
Antagonism between camptothecin and topoisomerase II-directed chemotherapeutic agents in a human leukemia cell line.
Topics: Amsacrine; Aphidicolin; Blotting, Western; Camptothecin; Colony-Forming Units Assay; Cycloheximide; Daunorubicin; Deoxyadenosines; Dichlororibofuranosylbenzimidazole; Diterpenes; DNA Polymerase II; DNA Replication; Drug Synergism; Etoposide; Female; Humans; Leukemia, Promyelocytic, Acute; Mutagens; RNA; Topoisomerase II Inhibitors; Topotecan; Tumor Cells, Cultured | 1991 |
Effects of deoxyribonucleic acid-reactive drugs on ribonucleic acid synthesis in leukemia L1210 cells.
Topics: Acridines; Acrylamides; Alkaloids; Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Benzazepines; Camptothecin; Carbazoles; Carbon Isotopes; Cell Nucleolus; Cell Nucleus; Centrifugation, Density Gradient; Dactinomycin; Daunorubicin; Deoxyadenosines; DNA, Neoplasm; Ethidium; Leukemia L1210; Mechlorethamine; Methionine; Phenanthridines; Pyridines; Pyrroles; RNA, Neoplasm; Tritium; Uridine | 1972 |
Effects of cytosine arabinoside, daunomycin, mithramycin, azacytidine, adriamycin, and camptothecin on mammalian cell cycle traverse.
Topics: Animals; Antineoplastic Agents; Autoradiography; Azacitidine; Camptothecin; Cell Division; Cell Line; Cricetinae; Cytarabine; Daunorubicin; DNA; DNA Replication; Doxorubicin; Mitosis; Plicamycin; Thymidine; Tritium | 1972 |
Topoisomerase poisons activate the transcription factor NF-kappaB in ACH-2 and CEM cells.
Topics: Antioxidants; Camptothecin; Cell Line; Cycloheximide; Dactinomycin; Daunorubicin; DNA; DNA Damage; DNA Topoisomerases, Type I; Etoposide; HIV-1; NF-kappa B; Nucleic Acid Synthesis Inhibitors; Poly(ADP-ribose) Polymerase Inhibitors; Topoisomerase I Inhibitors; Transcriptional Activation; Virus Activation | 1996 |
Increased gadd153 messenger RNA level is associated with apoptosis in human leukemic cells treated with etoposide.
Topics: Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; CCAAT-Enhancer-Binding Proteins; Daunorubicin; DNA Fragmentation; DNA-Binding Proteins; Etoposide; HL-60 Cells; Humans; Leukemia; Nuclear Proteins; RNA, Messenger; Serine Proteinase Inhibitors; Transcription Factor CHOP; Transcription Factors; Tumor Cells, Cultured | 1997 |
Inhibition of DNA unwinding and ATPase activities of human DNA helicase II by chemotherapeutic agents.
Topics: Adenosine Triphosphatases; Amsacrine; Antineoplastic Agents; Aphidicolin; Camptothecin; Dactinomycin; Daunorubicin; DNA; DNA Helicases; Ellipticines; Enzyme Inhibitors; Ethidium; Etoposide; Genistein; Humans; Isoflavones; Nogalamycin; Novobiocin; Topoisomerase I Inhibitors | 1997 |
Inhibition of pea chloroplast DNA helicase unwinding and ATPase activities by DNA-interacting ligands.
Topics: Adenosine Triphosphatases; Adenosine Triphosphate; Amsacrine; Camptothecin; Chloroplasts; Dactinomycin; Daunorubicin; DNA Helicases; Ellipticines; Ethidium; Etoposide; Genistein; Hydrolysis; Intercalating Agents; Ligands; Nogalamycin; Novobiocin; Pisum sativum | 1998 |
Anthracyclines trigger apoptosis of both G0-G1 and cycling peripheral blood lymphocytes and induce massive deletion of mature T and B cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; B-Lymphocytes; Camptothecin; Cell Cycle; Cells, Cultured; Daunorubicin; Doxorubicin; Etoposide; Fluorouracil; G1 Phase; Humans; Lymph Nodes; Lymphocyte Depletion; Lymphocytes; Methotrexate; Mice; Mice, Inbred BALB C; Resting Phase, Cell Cycle; Spleen; T-Lymphocytes; Thymus Gland | 2000 |
Reactive oxygen species-specific mechanisms of drug resistance in paraquat-resistant acute myelogenous leukemia sublines.
Topics: Alkynes; Antineoplastic Agents; Camptothecin; Cell Survival; Cisplatin; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Glutathione Transferase; Glycine; Humans; Leukemia, Myeloid, Acute; Metallothionein; Paraquat; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Superoxide Dismutase; Tumor Cells, Cultured; Vincristine | 2000 |
Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells.
Topics: Adult; Annexin A5; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Apoptosis; Biomarkers; Blotting, Western; Bone Marrow Cells; Camptothecin; Caspase 3; Caspase 7; Caspases; Daunorubicin; Enzyme Activation; Enzyme Inhibitors; Flow Cytometry; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Humans; Idarubicin; Leukemia; Peptide Hydrolases; Protein Binding; U937 Cells | 2000 |
Analysis of drug uptake-flow cytometry.
Topics: Anthracyclines; Antineoplastic Agents; Biological Transport; Camptothecin; Daunorubicin; Drug Resistance, Multiple; Enzyme Inhibitors; Erythrocytes; Flow Cytometry; Fluorescent Dyes; Kinetics; Liposomes; Molecular Structure; Prodrugs; Serum Albumin; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 2001 |
Paclitaxel sensitization of multidrug-resistant cells to chemotherapy is independent of the cell cycle.
Topics: Amsacrine; Antineoplastic Agents; Camptothecin; Carcinoma, Small Cell; Cell Cycle; Cell Survival; Chlorambucil; Cisplatin; Daunorubicin; Drug Resistance, Multiple; Epirubicin; Genistein; Humans; Lung Neoplasms; Paclitaxel; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2001 |
The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Clone Cells; Colchicine; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Daunorubicin; DNA Damage; DNA, Neoplasm; Etoposide; Fluorouracil; Gene Expression Regulation, Neoplastic; Genes, p53; Humans; Lung Neoplasms; Models, Biological; Proline; Promoter Regions, Genetic; Protein Structure, Tertiary; Recombinant Fusion Proteins; Structure-Activity Relationship; Tetracycline; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Protein p53 | 2002 |
Homocamptothecin-daunorubicin association overcomes multidrug-resistance in breast cancer MCF7 cells.
Topics: Adenocarcinoma; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Camptothecin; Carcinoma; Colonic Neoplasms; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; In Vitro Techniques; Leukemia, Myeloid; Microbial Sensitivity Tests; Multidrug Resistance-Associated Proteins; Polymerase Chain Reaction; RNA, Neoplasm; Treatment Outcome; Tumor Cells, Cultured | 2002 |
Reversal of multidrug resistance-associated protein-mediated daunorubicin resistance by camptothecin.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Camptothecin; Cell Line; Cell Nucleus; Chemokines, CC; Daunorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluorescent Antibody Technique; Gene Expression Regulation, Neoplastic; Humans; Leukemia; Microscopy, Confocal; Reverse Transcriptase Polymerase Chain Reaction; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2002 |
Functional validation of the genetic polymorphisms of human ATP-binding cassette (ABC) transporter ABCG2: identification of alleles that are defective in porphyrin transport.
Topics: Adenosine Triphosphate; Alleles; Animals; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Camptothecin; Cell Line; Cell Survival; Chlorophyll; Daunorubicin; Doxorubicin; Drug Resistance; Hematoporphyrins; Humans; Irinotecan; Kinetics; Methotrexate; Mitoxantrone; Mutant Proteins; Mutation; Neoplasm Proteins; Polymorphism, Single Nucleotide; Porphyrins; Spodoptera; Transfection | 2006 |
Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Cell Line, Tumor; Cisplatin; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Synergism; Floxuridine; Humans; Irinotecan; Liposomes; Mice; Neoplasms; Xenograft Model Antitumor Assays | 2006 |
Involvement of caspase-8 in chemotherapy-induced apoptosis of patient derived leukemia cell lines independent of the death receptor pathway and downstream from mitochondria.
Topics: Antineoplastic Agents; Apoptosis; Camptothecin; Caspase 8; Caspase 9; Cell Line, Tumor; Daunorubicin; Enzyme Activation; Humans; Leukemia; Mitochondria; Receptors, Death Domain | 2007 |
The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; B-Lymphocytes; Camptothecin; Carboplatin; Cell Proliferation; Cell Survival; Cells, Cultured; Cisplatin; Daunorubicin; Enzyme Inhibitors; Etoposide; Exodeoxyribonucleases; Genotype; Humans; Platinum Compounds; Polymorphism, Single Nucleotide; RecQ Helicases; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Topoisomerase Inhibitors; Werner Syndrome; Werner Syndrome Helicase | 2009 |
Inhibition of unwinding and ATPase activities of pea MCM6 DNA helicase by actinomycin and nogalamycin.
Topics: Adenosine Triphosphatases; Camptothecin; Cisplatin; Dactinomycin; Daunorubicin; DNA Helicases; Ellipticines; Enzyme Inhibitors; Etoposide; Intercalating Agents; Mitoxantrone; Nogalamycin; Novobiocin; Pisum sativum; Plant Proteins | 2011 |
Synthesis and Characterization of Micelle-Forming PEG-Poly(Amino Acid) Copolymers with Iron-Hydroxamate Cross-Linkable Blocks for Encapsulation and Release of Hydrophobic Drugs.
Topics: Amino Acids; Anhydrides; Animals; Antineoplastic Agents; Camptothecin; Daunorubicin; Drug Compounding; Drug Delivery Systems; Drug Liberation; Ferric Compounds; Hydrophobic and Hydrophilic Interactions; Hydroxamic Acids; Irinotecan; Micelles; Polyethylene Glycols; Polymerization; Rats; Rats, Inbred F344; Stereoisomerism | 2017 |